President-elect Donald Trump on Friday named Johns Hopkins University surgeon Marty Makary to lead the Food and Drug ...

The Food and Drug Administration has approved a new medicine for a deadly genetic heart condition, boosting its developer, BridgeBio Pharma, and teeing up a battle for control of a lucrative market ...

Lexicon Pharmaceuticals will lay off 60% of its workforce and eliminate its commercial organization in a restructuring meant to save $100 million in operating costs next year. The shakeup follows ...

Evotec appears to have rebuffed Halozyme’s $2.1 billion acquisition attempt. Elsewhere, Argenx has another blockbuster target ...

In buying Westlake-backed Kate Therapeutics, Novartis gets a handful of preclinical gene therapies targeting diseases like ...

The startup, Pep2Tango, is combining four methods of accelerating weight loss into one medicine in the hopes of developing a ...

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...

Venture capital firms incubate, grow and finance dozens of drug companies each year. Follow the money they channel into the ...

Despite plans to shutter 1,200 stores, the company’s chief clinical trials officer said the pharmacy giant remains committed ...

Built around research by Stanford scientist Carolyn Bertozzi and MIT researcher Jessica Stark, Valora Therapeutics is ...